Epidemiological study to clarify the association between systemic drug use and the risk of glaucoma using Japanese claims data.

Epidemiological study to clarify the association between systemic drug use and the risk of glaucoma using Japanese claims data. - Epidemiological study of glaucoma patients using Japanese claims data.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040585

Enrollment

20000

Registered

2020-05-31

Start date

2020-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with newly prescribed systemic drug, newly prescribed topical glaucoma drug, and newly diagnosed glaucoma (defined as code H401, H409 in the ICD-10) using Japanese regional claims data between January 1, 2015 to December 21, 2017.

Exclusion criteria

Exclusion criteria: Patients who did not meet the inclusion criteria.

Design outcomes

Primary

Measure	Time frame
First day of exposure (systemic drug prescription) and event (topical glaucoma drug prescription or glaucoma diagnosis)	—

Countries

Japan

Contacts

Public ContactChikako Shirai

Tohoku University Graduate School of Medicine Department of Ophthalmology

chikako.shirai@med.tohoku.ac.jp022-717-7294

Outcome results